Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jess Louise Smith"'
Autor:
Michael Millward, Jess Louise Smith, Timothy C. Wang, Simone M. Goldinger, Robert M. Conry, Ashlyn S. Everett, Ines Pires da Silva, G. Daniel Grass, Zeynep Eroglu, Victoria Atkinson, Douglas B. Johnson, Patricia Banks, Rachel Roberts-Thomson, Lauren E. Haydu, Mark Shackleton, Angela Hong, Alexander M. Menzies, Georgina V. Long, Isabella C. Glitza, Romany A. N. Johnpulle
Publikováno v:
Journal of Clinical Oncology. 35:9513-9513
9513 Background: Melanoma brain metastases confer poor prognosis, with various treatments used including RT and PD1. While RT and PD1 may have a synergistic effect to improve efficacy, RN may complicate RT, and whether PD1 potentiates this is unknown
Autor:
Zeynep Eroglu, Sophie Feng, John J. Park, Katy K. Tsai, Alpaslan Özgün, Victoria Atkinson, Alexander M. Menzies, Jennifer L. McQuade, Andrew P.D. Henderson, Shahneen Sandhu, Georgina V. Long, Ryan J. Sullivan, Lavinia Spain, Matteo S. Carlino, Jess Louise Smith, Justine V. Cohen, James Larkin, Douglas B. Johnson, Margarida Mut Lioret
Publikováno v:
Journal of Clinical Oncology. 35:e21641-e21641
e21641 Background: The anti-PD1 antibodies (PD1) pembrolizumab and nivolumab are now FDA-approved in multiple malignancies. With increased use, rarer immune-related adverse events (irAEs) not well characterized in clinical trials are being identified